IRVINE, Calif.--(BUSINESS WIRE)--Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against ReWalk Robotics Ltd (“ReWalk” or the “Company”) (Nasdaq: RWLK). Investors who purchased or otherwise acquired ReWalk shares pursuant and/or traceable to the Company’s Stock Offering on or about September 12, 2014 are encouraged to contact the firm in advance of the March 27, 2017 lead plaintiff motion deadline.
If you purchased shares of ReWalk during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or via e-mail at email@example.com.
The Complaint alleges that the Registration Statement and Prospectus issued in regards with the Initial Public Offering did not disclose material information, including that ReWalk could not comply with “special controls” requirements or to offer the U.S. Food and Drug Administration with a postmarket surveillance study. When this information was announced to the public, the value of ReWalk fell, causing investors harm.
There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.
If you wish to learn more about this lawsuit at no charge, or if you have questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at firstname.lastname@example.org.
This press release may constitute Attorney Advertising in some jurisdictions.